Breast cancer awareness shouldn’t end when October is over. That was tennis champion Serena Williams‘ message after sharing that she has very dense breast tissue and has to be especially thorough with her routine screenings.
“A morning full of breast exams. Top on, top off, top on, top off!” Williams wrote in a Nov. 2 post on X, urging women to stay on top of their breast health year-round rather than only during Breast Cancer Awareness Month. She explained that her breast density is a key reason she stays diligent about regular imaging.
Williams did not share her exam results or report a cancer diagnosis. Instead, she used her experience to highlight a common finding that many women don’t fully understand: while dense breast tissue is normal, it can make tumors harder to spot on a mammogram and slightly increase a person’s risk of developing breast cancer.
What does it mean to have dense breast tissue?
Breast density describes how much glandular and fibrous tissue a person has compared with fatty tissue. The milk-producing glands and milk ducts are composed of glandular tissue, with fibrous tissue present for support.
Breasts with more glandular and fibrous tissue and less fat are classified as dense.This is a normal finding; it is not a disease, and it does not mean someone has cancer.
The National Cancer Institute (NCI) estimates that almost 50% of women age 40 and older who undergo mammograms have dense breast tissue. Radiologists rate breast density across four categories:
- Almost entirely fatty
- Scattered areas of fibroglandular density
- Heterogeneously dense
- Extremely dense
Williams’ description of having “very dense” breasts aligns with the extremely dense category, which affects roughly 10% of women.
Breast density can be inherited, though it also shifts over time and may be influenced by age, pregnancy, body weight and hormone use. Importantly, you cannot feel breast density during a self-exam—it can only be identified on a mammogram.
Why can dense breasts make cancer harder to detect on mammograms?
On a mammogram, fatty tissue appears dark or transparent, making abnormal spots easier to see. Dense glandular and fibrous tissue appears white, which can mask tumors or other concerning changes.
Kristin Robinson, MD, a breast radiologist at Mayo Clinic, explains the challenge: “The dense tissue on a mammogram looks white, and cancer looks white.”
Because of this overlap, mammograms can be less sensitive in people with dense breasts, meaning certain cancers are harder to spot. Even so, regular mammograms remain essential, as many breast cancers are still detected in dense tissue. Your health care provider can help you determine whether additional imaging is needed.
Do dense breasts increase your risk of developing cancer?
Yes. Compared with women who have mostly fatty breast tissue, women with dense breast tissue are at an increased risk for breast cancer.
Breast density is a risk factor on its own, according to the CDC. This means it could impact cancer risk in and of itself, apart from its impact on mammogram accuracy.
Still, having dense breasts does not mean a person will develop cancer. Other factors shape overall risk, including family history, inherited genetic mutations (such as BRCA1 and BRCA2), age, and a history of breast biopsies showing high-risk changes. For example, someone with dense breasts and a strong family history may need a different screening plan than someone whose only risk factor is breast density.
Justus Rabach, MD, a Blavity Health medical reviewer, reminds readers: “One of the biggest myths about breast cancer is that it’s mostly hereditary. Many people believe that if no one in their family has had it, they’re probably safe. But this belief is dangerously wrong. The truth is clear: most people diagnosed with breast cancer have no family history of the disease. Understanding why a breast cancer diagnosis can happen without family history is critical for your health.”
What additional screenings are available for women with dense breasts?
Some people with dense breasts may benefit from supplemental imaging to look for abnormalities that a standard mammogram might miss. Options include:
- 3D mammography (digital breast tomosynthesis): Captures multiple X-ray angles to create a layered image of the breast, improving cancer detection in dense tissue compared with traditional 2D mammograms.
- Breast ultrasound: Uses sound waves to create images of breast tissue and can help spot abnormalities hidden on mammograms.
- Breast MRI: Uses magnetic fields and radio waves to produce detailed images and may be recommended for people at higher overall risk of breast cancer.
- Contrast-enhanced mammography: Pairs an intravenous contrast dye with X-rays to highlight areas with increased blood flow that may warrant closer evaluation.
False-positive results (the detection of noncancerous or benign masses, such as cysts, fibroadenomas and scar tissue) are common with ultrasound and MRI imaging tests and often lead to further testing, unnecessary biopsies and additional costs for both patients and the healthcare system.
There is still preliminary evidence on which patients with dense breasts would benefit most from supplemental screening. The U.S. Preventive Services Task Force (USPSTF) says there is not enough evidence to recommend for or against routine supplemental ultrasound or MRI after a normal mammogram for everyone with dense breasts. Meanwhile, the American College of Radiology recommends that other factors, such as breast density and individual risk, be taken into account when deciding whether to have additional screening.
What this means for patients: Having “dense” breasts does not necessarily require an MRI or ultrasound. Discuss any personal risk and imaging results with your health care professional to determine if further imaging is beneficial.
When should women start getting mammograms and how often should they be screened?
The USPSTF advises women at average risk to start screening at age 40. It recommends screening every 2 years until age 74. This updated guidance replaced an earlier recommendation that left screening decisions in a woman’s 40s up to individual preference.
Other medical institutions have different schedules. For instance, women at average risk are advised by the American College of Radiology to have a mammogram every year starting at age 40.
Men and women who have a strong family history, inherited genes or a history of breast cancer may require screening at an earlier age or other tests. Screening plans should be tailored to individuals’ risks and professional guidance.
It’s also important to recognize the distinction between routine screening and diagnostic testing. If you notice a new lump, nipple discharge, skin dimpling, or any other breast change, contact a health care provider promptly rather than waiting for your next scheduled screening mammogram.
Why are breast cancer screening disparities a concern for Black women?
Not all racial groups are affected equally by breast cancer. According to the USPSTF, Black women are about 40% more likely to die from breast cancer than white women.
Black women are also more likely to be diagnosed at a later stage and at younger ages, and they face higher rates of triple-negative breast cancer, a particularly aggressive subtype.
These disparities stem from more than just screening rates. Systemic barriers—including unequal access to timely follow-up imaging, prompt diagnostic testing, and high-quality treatment—play a significant role.
A mammogram is only the first step in early detection. Anyone who receives an abnormal result needs timely follow-up appointments, appropriate supplemental imaging,and seamless access to care. Empowering Black women against breast cancer requires not only encouraging consistent screening, but also dismantling the barriers that delay diagnosis and treatment.
What should you ask your doctor if your mammogram shows dense breast tissue?
Under a national U.S. Food and Drug Administration (FDA) rule, mammography facilities are required to notify patients in their summary letters whether their breasts are classified as “dense” or “not dense,” giving patients clear information to review with their health care providers.
Consider asking:
- Are my breasts heterogeneously dense or extremely dense?
- How does my breast density affect my breast cancer risk?
- Does my family history suggest that I need additional screening?
- Would an ultrasound, MRI, or another imaging test benefit me?
- When should I schedule my next mammogram?
Also note any prior abnormal mammograms, breast biopsies, or family history of hereditary abnormalities associated with the development of cancer.
Bottom line
Serena Williams’ message underscores why breast cancer awareness and screening matter all year long. Dense breasts are common and normal, but they can make tumors harder to spot on a mammogram and slightly raise breast cancer risk. Knowing your breast density and reviewing your personal risk factors with a health care provider can help ensure you get the screening plan best suited for you.
Frequently Asked Questions
Is having dense breasts genetic?
Yes, breast density often runs in families, although age, hormone use, pregnancy, and other factors can also influence it.
Can breast density change as you get older?
Yes, breast density often decreases with age, although the amount of change varies from person to person.
Citations
National Cancer Institute. Dense Breasts: Answers to Commonly Asked Questions. Cancer.gov. October 19, 2026. Accessed November 12, 2026. https://www.cancer.gov/types/breast/screening/dense-breasts
CDC. About Dense Breasts. Breast Cancer. April 25, 2024. Accessed November 12, 2026. https://www.cdc.gov/breast-cancer/about/dense-breasts.html
U.S. Preventive Services Task Force. Breast cancer: Screening. U.S. Preventive Services Task Force. April 30, 2024. Accessed November 12, 2026. https://www.uspreventiveservicestaskforce.org/uspstf/recommendation/breast-cancer-screening
Yeh ED, Brown A, Freer PE, et al. ACR Appropriateness Criteria® Female Breast Cancer Screening: 2025 Update. ACR Appropriateness Criteria®–November 2025. 2025;22(11, Supplement):S508-S530. doi:10.1016/j.jacr.2025.08.044
FDA. FDA Updates Mammography Regulations to Require Reporting of Breast Density Information and Enhance Facility Oversight. FDA. March 10, 2023. Accessed November 12, 2026. https://www.fda.gov/news-events/press-announcements/fda-updates-mammography-regulations-require-reporting-breast-density-information-and-enhance

